HEALTH.2011.1.4-2
HEALTH.2011.1.4-2
8 projects · €44,059,987 total EU contribution (project-level) · 75 participating organizations · 20 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€44,059,987
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (19)
- UK (11)
- Spain (8)
- Italy (8)
- BE (3)
- CH (3)
- France (3)
- SE (3)
- CZ (2)
- IL (2)
- Netherlands (2)
- PT (2)
- AT (1)
- CA (1)
- DK (1)
- FI (1)
- HR (1)
- NO (1)
- PL (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- EURAM LIMITED2 projects · UK
- UNIVERSITY OF EASTERN FINLAND (UEF)2 projects · FI
- MHH2 projects · DE
- QMUL2 projects · UK
- CELL2 projects · SE
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2 projects · UK
- UNIVERSITY COLLEGE LONDON2 projects · —
- ALTA1 projects · PT
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- CARDIOVASCULAR RESEARCH CENTER AALST VZW1 projects · BE
- Cellec1 projects · CH
- CellTool GmbH1 projects · DE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Bioreactor-based, clinically oriented manufacturing of engineered tissues BIO-COMET · 278807 | FP7 | €5,994,367 | €8,326,237 | Details |
Tissue in Host Engineering Guided Regeneration of Arterial Intimal Layer THE GRAIL · 278557 | FP7 | €5,998,438 | €7,804,024 | Details |
Biohybrid templates for peripheral nerve regeneration BIOHYBRID · 278612 | FP7 | €5,922,000 | €7,755,600 | Details |
Innovative strategies to generate human hepatocytes for treatment ofmetabolic Liver diseases: Tools for personalized cell therapy InnovaLiv · 278152 | FP7 | €5,884,171 | €7,682,012 | Details |
Biodegradable Magnetic Stent for Coronary Artery Luminal Regeneration BIOMAGSCAR · 278313 | FP7 | €5,299,478 | €6,799,138 | Details |
Identification, homing and monitoring of therapeutic cells for regenerative medicine – Identify, Enrich, Accelerate IDEA · 279288 | FP7 | €5,897,395 | €7,662,776 | Details |
The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction BAMI · 278967 | FP7 | €5,993,083 | €7,842,161 | Details |
THE PRODUCTION OF A 3D HUMAN TISSUE DISEASE PLATFORM TO ENABLE REGENERATIVE MEDICINE THERAPY DEVELOPMENT TissueGEN · 278955 | FP7 | €3,071,055 | €4,291,627 | Details |